SEGMENT AND RELATED INFORMATION

12 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

SEGMENT AND RELATED INFORMATION

NOTE 16 - SEGMENT AND RELATED INFORMATION

The Company provides segment data in accordance with the provisions of ASC 280, “Disclosures about Segments of an Enterprise and Related Information”.

The Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging centers.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance based on income or loss from operations.

Summarized financial information concerning the Company’s reportable segments is shown in the following table:

	Manufacturing and Servicing of Medical			Management of Diagnostic Imaging
Fiscal 2024:	Equipment			Center		Totals
Net revenues from external customers	$	8,329,106		$	94,554,983	$	102,884,089
Intersegment net revenues *	$	1,073,333		$	—	$	1,073,333
(Loss) Income from operations	$	(6,958,012	)	$	23,493,376	$	16,535,364
Depreciation and amortization	$	238,802		$	4,357,619	$	4,596,421
Total identifiable assets	$	30,360,188		$	183,885,781	$	214,245,969
Capital expenditures	$	32,885		$	789,961	$	822,846
Fiscal 2023:
Net revenues from external customers	$	8,260,711		$	90,384,390	$	98,645,101
Intersegment net revenues *	$	985,833		$	—	$	985,833
(Loss) Income from operations	$	(5,875,126	)	$	20,664,388	$	14,789,262
Depreciation and amortization	$	263,720		$	4,276,415	$	4,540,135
Total identifiable assets	$	30,892,807		$	170,153,612	$	201,046,419
Capital expenditures	$	119,571		$	4,218,084	$	4,337,655

* Amounts eliminated in consolidation

Export Product Sales

The Company’s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting to 0.2% and 14.1% of product sales revenues to third parties for the years ended June 30, 2024 and 2023, respectively.

The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:

	For the Years Ended June 30
	2024			2023
Canada		0.2	%		8.5	%
Germany		—			4.9	%
United Arab Emirates		—			0.7	%
		0.2	%		14.1	%

Foreign Service and Repair Fees

The Company’s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to 7.4% and 6.4% of consolidated net service and repair fees for the years ended June 30, 2024 and 2023, respectively. Foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:

 Foreign Service and Repair Fees

	For the Years Ended June 30,
	2024			2023
Puerto Rico		1.9	%		1.5	%
Switzerland		0.3			0.3
Germany		2.0			1.6
England		0.7			0.6
United Arab Emirates		0.3			0.1
Dominican Republic		1.2			0.5
Canada		—			0.6
Greece		0.3			0.3
Australia		0.7			0.9
		7.4	%		6.4	%

 The Company does not have any material assets outside of the United States.